Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Folliculin deficiency causes problems with cell division and positioning due to disrupted RhoA signaling and interaction with p0071.

Manipulating 5α-reductase type 2 can affect liver fat production and glucocorticoid effects.

Finasteride effectively inhibits the enzyme steroid 5 alpha-reductase II.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

5α-reductases increase epitestosterone's effect on androgen receptors.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.

The substance MK386 effectively blocked testosterone conversion and reduced cell growth in certain skin cells, but inhibiting 5α-reductase alone may not greatly improve acne.

The structure of SRD5A reveals how it reduces steroids, aiding drug design for related health conditions.

The research helps understand how finasteride works and aids drug development.

LH and hCG reduce certain protein levels in women's skin.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

A new method was developed to measure and assess the activity and inhibition of the enzyme steroid 5α-reductase.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

The human type II 5α-reductase gene has a specific structure important for understanding certain medical conditions.

New compounds may soon be tested to treat excessive hair growth in women.

Efficient enzyme function relies on specific residue interactions and structural coordination.

We need to learn more about 5α-reductases and neuroactive steroids to safely make drugs targeting these enzymes.

Lack of 5α-Reductase type 1 can lead to insulin resistance and liver problems.

Benzo[c]quinolizin-3-ones are effective nonsteroidal inhibitors of human steroid 5α-reductase 1.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Certain mutations in the H6PD gene cause Cortisone Reductase Deficiency by affecting hormone production.

The human type II 5α-reductase gene, linked to certain male health conditions, has a specific structure and low similarity to other related genes.

Androgens regulate 5 alpha-reductase activity in hamster sebaceous glands.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.